TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Corbus Pharmaceuticals Announces Pricing of Public Offering

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Sean Moran
Corbus Pharmaceuticals Announces Pricing of Public Offering

Corbus Pharmaceuticals plans to raise approximately $75 million through a public offering of 4,744,231 common stock shares and pre-funded warrants, with proceeds intended to fund clinical development and working capital.

Insights
GSpD   neutral

Mentioned as Crowder's former employer, no specific positive or negative context


CRBP   neutral

The company is raising capital through a standard public offering to fund ongoing clinical development, which indicates a typical financing strategy without significant positive or negative implications